Brucellosis/Undulant Fever (Brucella species)
For the why behind the fact
Use this page to connect what you are memorizing.
Start with the overview when a class slide, Anki card, or qbank explanation feels too thin. Then use presentation and workup to recognize the condition, and differentials to separate look-alikes.
Overview
Plain-Language Overview
Brucellosis/Undulant Fever is an infection caused by bacteria called Brucella species that mainly affects the immune system and various organs. It is often transmitted to humans through contact with infected animals or consuming unpasteurized dairy products. The infection causes recurrent fevers, sweating, and muscle pain, which can come and go over weeks to months. It primarily affects the reticuloendothelial system, including the liver, spleen, and lymph nodes, leading to symptoms like fatigue and joint pain. This disease can cause long-lasting health problems if not properly diagnosed and treated.
Clinical Definition
Brucellosis/Undulant Fever is a systemic zoonotic infection caused by facultative intracellular gram-negative coccobacilli of the genus Brucella. The bacteria invade and survive within macrophages, leading to chronic granulomatous inflammation primarily involving the reticuloendothelial system. Transmission occurs through direct contact with infected animals or ingestion of contaminated animal products, especially unpasteurized milk. The disease is characterized by intermittent fever spikes (undulant fever), night sweats, arthralgia, and hepatosplenomegaly. It can cause complications such as osteomyelitis, endocarditis, and chronic fatigue. Diagnosis and management are critical due to its potential for chronicity and systemic involvement.
Inciting Event
Ingestion of unpasteurized milk or cheese contaminated with Brucella species initiates infection.
Direct contact with infected animal tissues or fluids through skin abrasions or mucous membranes triggers disease.
Inhalation of aerosolized bacteria in laboratory or slaughterhouse settings can cause infection.
Handling of aborted animal fetuses or placentas is a common source of bacterial entry.
Consumption of undercooked meat from infected animals may also serve as an inciting event.
Latency Period
Symptoms usually begin after several weeks; incubation varies and can extend for months.
Symptoms may appear as early as 5 days or as late as several months post-infection.
Relapse or focal persistent infection can follow the initial illness; prolonged fatigue alone does not prove ongoing viable infection.
Relapsing fever episodes may occur weeks after initial symptom resolution.
Latency varies depending on bacterial load and host immune response.
Diagnostic Delay
Nonspecific symptoms such as fever, malaise, and arthralgia often mimic other febrile illnesses causing delay.
Low clinical suspicion in non-endemic areas leads to missed or late diagnosis.
Slow growth of Brucella in blood cultures delays microbiological confirmation.
Serologic tests may be negative early in disease, requiring repeat testing.
Overlap with other infections like tuberculosis or typhoid fever complicates diagnosis.
Clinical Presentation
Signs & Symptoms
Fever may be intermittent, prolonged or undulating; a classic oscillating pattern is not required.
Night sweats and fatigue are frequently reported systemic symptoms.
Arthralgia and myalgia commonly affect large joints and muscles.
Weight loss and anorexia occur due to chronic infection.
Headache and malaise are nonspecific but common complaints.
History of Present Illness
Fever with sweats, fatigue and arthralgia is characteristic, but the pattern is variable and not diagnostic by itself.
Fatigue, malaise, and weight loss develop gradually over weeks to months.
Arthralgia and myalgia commonly affect large joints and the lower back.
Headache and hepatosplenomegaly may be present in systemic involvement.
Symptoms often relapse after initial improvement without treatment.
Past Medical History
Previous exposure to livestock or unpasteurized dairy products increases suspicion for brucellosis.
History of travel to or residence in endemic areas is relevant for risk assessment.
Prior episodes of febrile illness with incomplete resolution may indicate chronic infection.
Immunosuppressive conditions or therapies can worsen disease severity and prolong course.
No specific genetic predisposition is typically noted in past medical history.
Family History
There is no known hereditary pattern or familial syndrome associated with brucellosis.
Family members may share exposure risk if living in the same endemic environment or consuming the same contaminated products.
Clusters of cases in families often reflect common environmental or occupational exposures rather than genetic factors.
This is an acquired infection, not a routinely inherited disorder; shared exposures are more clinically useful than genetic testing.
Ask about similarly ill household members and shared dairy/animal exposures to identify common-source cases.
Physical Exam Findings
Hepatosplenomegaly is a common finding due to reticuloendothelial system involvement.
Lymphadenopathy may be present reflecting systemic infection.
Fever is often observed during examination, typically with an undulating pattern.
Arthritis or arthralgia may be noted in affected joints, especially large joints.
Endocarditis signs such as new heart murmurs can occur in severe cases.
Diagnostic Workup
Diagnostic Criteria
Use compatible illness and animal/food/occupational exposure with culture and appropriate serology. Notify the laboratory before submitting suspected Brucella specimens because of aerosol-acquired infection risk. Routine smooth-Brucella antibody tests do not detect B. canis or B. abortus RB51. A negative early serology or culture does not exclude disease; paired serology, specialized testing and focal-site evaluation may be needed.
Pathophysiology
Key Mechanisms
Facultative intracellular Brucella survives in macrophages; the VirB type IV secretion system helps establish an endoplasmic-reticulum-associated replicative compartment.
Granulomatous inflammation develops in reticuloendothelial organs causing tissue damage and systemic symptoms.
Host inflammatory responses generate fever and malaise. Brucella LPS has relatively low endotoxic activity; intracellular persistence and immune evasion are central to disease.
Chronic infection results from the bacteria's ability to persist in phagocytic cells leading to relapsing symptoms.
Hematogenous dissemination spreads infection to multiple organ systems including bones and joints.
| Involvement | Details |
|---|---|
| Organs | Liver is frequently affected, often showing granulomatous hepatitis in chronic brucellosis. |
Spleen enlargement occurs due to immune activation and bacterial persistence within the reticuloendothelial system. | |
| Tissues | Reticuloendothelial tissue including lymph nodes and spleen is commonly involved due to Brucella intracellular localization. |
Bone marrow involvement can lead to hematologic abnormalities and is a site of chronic infection. | |
| Cells | Macrophages are the primary host cells where Brucella species survive intracellularly, evading immune clearance. |
T lymphocytes mediate the cell-mediated immune response essential for controlling chronic brucellosis. | |
| Chemical Mediators | Interferon-gamma is critical for activating macrophages to kill intracellular Brucella organisms. |
Tumor necrosis factor-alpha contributes to granuloma formation and systemic inflammatory symptoms in brucellosis. |
Treatments
Pharmacological Treatments
Doxycycline
- Mechanism:
Inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit.
- Side effects:
Photosensitivity
Gastrointestinal upset
Tooth discoloration in children
- Clinical role:
Common adult regimen: doxycycline plus rifampin for at least 6 weeks for uncomplicated susceptible-strain infection. Do not use doxycycline alone; focal complicated disease needs specialist combinations and often longer treatment.
Rifampin
- Mechanism:
Inhibits bacterial DNA-dependent RNA polymerase, blocking RNA synthesis.
- Side effects:
Hepatotoxicity
Orange discoloration of body fluids
Drug interactions
- Clinical role:
Partner in prolonged combination treatment, not monotherapy. Do not use for B. abortus RB51, which is rifampin-resistant; review major enzyme-inducing drug interactions.
Streptomycin
- Mechanism:
Binds to the 30S ribosomal subunit causing misreading of mRNA and inhibiting protein synthesis.
- Side effects:
Ototoxicity
Nephrotoxicity
Injection site pain
- Clinical role:
An initial aminoglycoside component with doxycycline is an alternative combination regimen, not simply rescue monotherapy. Gentamicin can be used in selected regimens; monitor renal and auditory toxicity.
Trimethoprim-sulfamethoxazole (TMP-SMX)
- Mechanism:
Sequential inhibition of bacterial folate synthesis through dihydropteroate synthase and dihydrofolate reductase.
- Side effects:
Hypersensitivity, including severe cutaneous reactions
Hyperkalemia and cytopenias; pregnancy/timing and renal function affect suitability
- Clinical role:
Combination-regimen option when doxycycline/rifampin is unsuitable; a partner with doxycycline for rifampin-resistant RB51. Pediatric/pregnancy and focal disease regimens require specialist selection.
Non-pharmacological Treatments
Evaluate focal complications and provide source control when indicated; endocarditis may need valve surgery and abscesses may require drainage in addition to antibiotics.
Support hydration, nutrition and symptom control; reassess recurrent fever or focal pain for complications, relapse, adherence problems or an alternative diagnosis.
Prevention
Pharmacological Prevention
Routine antibiotics for everyone in an endemic area are not indicated; prophylaxis is exposure- and risk-specific.
CDC recommends prompt two-drug PEP for at least 21 days after high-risk laboratory exposure, usually doxycycline plus rifampin. Substitute an effective partner such as TMP-SMX for RB51 exposure; arrange symptom monitoring for 24 weeks and serology when applicable.
Non-pharmacological Prevention
Avoiding unpasteurized dairy products is the most effective prevention method.
Use of protective equipment when handling potentially infected animals or tissues.
Livestock vaccination/control programs reduce human exposure. No routine human vaccine is available; live veterinary vaccines can infect exposed people.
Public health education on safe farming and food handling practices.
Screening and culling infected livestock to control outbreaks.
Outcome & Complications
Complications
Brucella endocarditis is the leading cause of mortality in brucellosis.
Osteomyelitis and spondylitis can cause chronic bone destruction.
Neurobrucellosis may lead to meningitis, encephalitis, or cranial nerve palsies.
Chronic arthritis can result in joint deformities and disability.
Abscess formation in liver, spleen, or other organs may occur.
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Brucellosis/Undulant Fever (Brucella species) versus Tuberculosis
Brucellosis/Undulant Fever (Brucella species) | Tuberculosis |
|---|---|
Exposure to livestock or consumption of unpasteurized dairy products | Exposure to individuals with active pulmonary tuberculosis or living in endemic areas |
Variable febrile systemic illness with osteoarticular involvement; granulomas may occur but are not a stand-alone discriminator. | TB may be pulmonary or extrapulmonary; necrotizing granulomas suggest TB but histology alone is not species-specific. |
Positive blood or bone marrow culture for Brucella species | M. tuberculosis-specific NAAT and culture/identification support diagnosis; AFB staining alone neither confirms species nor excludes TB when negative. |
Brucellosis/Undulant Fever (Brucella species) versus Typhoid Fever
Brucellosis/Undulant Fever (Brucella species) | Typhoid Fever |
|---|---|
Contact with infected animals or animal products | Ingestion of contaminated food or water in endemic areas |
Intermittent undulating fever with arthralgia and hepatosplenomegaly | Prolonged fever with variable abdominal/systemic symptoms; stepwise fever and relative bradycardia are not required. |
Culture or appropriately interpreted Brucella serology; routine serology does not detect B. canis/RB51. | Positive blood culture for Salmonella typhi |
Brucellosis/Undulant Fever (Brucella species) versus Infective Endocarditis
Brucellosis/Undulant Fever (Brucella species) | Infective Endocarditis |
|---|---|
Occupational exposure to farm animals or ingestion of unpasteurized dairy | Risk includes prosthetic valves, prior endocarditis, devices or injection drug use, but disease can occur without these. |
Systemic fever and osteoarticular symptoms; Brucella can itself cause endocarditis. | Fever, embolic findings and valve dysfunction may occur; a new murmur is not mandatory. |
Brucella identification does not exclude endocarditis; investigate compatible cardiac/systemic findings. | Integrate blood cultures, echocardiography and clinical criteria. Negative initial echo or cultures do not reliably exclude endocarditis. |
Brucellosis/Undulant Fever (Brucella species) versus Q Fever
Brucellosis/Undulant Fever (Brucella species) | Q Fever |
|---|---|
Direct contact with infected livestock or consumption of unpasteurized dairy | Exposure to aerosols from parturient animals, especially sheep and goats |
Chronic undulating fever with osteoarticular and systemic symptoms | Acute Q fever may cause pneumonia/hepatitis; persistent focal infection can cause endocarditis. |
Culture or species-appropriate Brucella testing interpreted with exposure. | Acute Q fever: early PCR or paired phase II IgG rise. Persistent focal infection: elevated phase I IgG plus a demonstrable focus, not antibody positivity alone. |
Brucellosis/Undulant Fever (Brucella species) versus Leptospirosis
Brucellosis/Undulant Fever (Brucella species) | Leptospirosis |
|---|---|
Exposure to farm animals or ingestion of unpasteurized dairy products | Exposure to water contaminated with animal urine, especially rodents |
Undulating fever with arthralgia and hepatosplenomegaly | Biphasic illness with abrupt fever, myalgia, conjunctival suffusion, and possible jaundice |
Culture or appropriately interpreted Brucella serology with species limitations. | PCR on an appropriately timed specimen or paired serology/MAT; early negative serology does not exclude leptospirosis. |